{"AllianceGenome": "21197", "HGNC": "21197", "MIM": "611026", "_id": "79152", "_version": 1, "accession": {"genomic": ["AC004685.1", "AC009132.9", "CH471114.2", "CP068262.2", "NC_000016.10", "NC_060940.1", "NG_017070.1"], "protein": ["AAC23496.1", "AAH02679.2", "AAH04263.2", "AAH17049.2", "BAB71632.1", "BAG37893.1", "BAH14072.1", "CAC20436.1", "EAW95677.1", "EAW95678.1", "NP_077282.3", "Q7L5A8.1", "XP_011521619.1", "XP_011521621.1", "XP_054169881.1", "XP_054169882.1"], "rna": ["AA857184.1", "AJ278219.1", "AK058016.1", "AK303878.1", "AK315512.1", "BC002679.2", "BC004263.1", "BC010453.1", "BC017049.1", "DA890369.1", "NM_024306.5", "XM_011523317.4", "XM_011523319.3", "XM_054313906.1", "XM_054313907.1"], "translation": [{"protein": "BAH14072.1", "rna": "AK303878.1"}, {"protein": "BAB71632.1", "rna": "AK058016.1"}, {"protein": "AAH17049.2", "rna": "BC017049.1"}, {"protein": "AAH04263.2", "rna": "BC004263.1"}, {"protein": "NP_077282.3", "rna": "NM_024306.5"}, {"protein": "XP_054169881.1", "rna": "XM_054313906.1"}, {"protein": "CAC20436.1", "rna": "AJ278219.1"}, {"protein": "XP_011521621.1", "rna": "XM_011523319.3"}, {"protein": "AAH02679.2", "rna": "BC002679.2"}, {"protein": "XP_054169882.1", "rna": "XM_054313907.1"}, {"protein": "XP_011521619.1", "rna": "XM_011523317.4"}, {"protein": "BAG37893.1", "rna": "AK315512.1"}]}, "alias": ["FAAH", "FAH1", "FAXDC1", "SCS7", "SPG35"], "ensembl": {"gene": "ENSG00000103089", "protein": ["ENSP00000219368", "ENSP00000455126", "ENSP00000464576", "ENSP00000479548"], "transcript": ["ENST00000219368", "ENST00000562145", "ENST00000567683", "ENST00000569949", "ENST00000618933"], "translation": [{"protein": "ENSP00000219368", "rna": "ENST00000219368"}, {"protein": "ENSP00000455126", "rna": "ENST00000567683"}, {"protein": "ENSP00000464576", "rna": "ENST00000569949"}, {"protein": "ENSP00000479548", "rna": "ENST00000618933"}], "type_of_gene": "protein_coding"}, "entrezgene": "79152", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.7075715443, "exp_mis": 131.207244324, "exp_syn": 68.5308258172, "lof_z": 2.97542774100611, "mis_z": 1.4179793069497, "mu_lof": 1.03583126552e-06, "mu_mis": 1.54532583806e-05, "mu_syn": 8.10047989383e-06, "n_lof": 2.0, "n_mis": 98.0, "n_syn": 63.0, "p_li": 0.726409723584695, "p_null": 0.000588175320066303, "p_rec": 0.273002101095238, "syn_z": 0.414187288369608}, "bp": 1119, "cds_end": 74808653, "cds_start": 74748087, "n_exons": 7, "nonpsych": {"exp_lof": 11.3816280175, "exp_mis": 118.635270198, "exp_syn": 61.9070645205, "lof_z": 2.73103960645807, "mis_z": 1.23342373649697, "mu_lof": 1.03583126552e-06, "mu_mis": 1.54532583806e-05, "mu_syn": 8.10047989383e-06, "n_lof": 2.0, "n_mis": 92.0, "n_syn": 60.0, "p_li": 0.64885837407548, "p_null": 0.00154066046834435, "p_rec": 0.349600965456176, "syn_z": 0.152601129599064}, "nontcga": {"exp_lof": 11.6792742869, "exp_mis": 120.698981341, "exp_syn": 63.0366751839, "lof_z": 2.79393378072134, "mis_z": 1.30144101822195, "mu_lof": 1.03583126552e-06, "mu_mis": 1.54532583806e-05, "mu_syn": 8.10047989383e-06, "n_lof": 2.0, "n_mis": 92.0, "n_syn": 55.0, "p_li": 0.652782340827826, "p_null": 0.00121883301910388, "p_rec": 0.345998826153071, "syn_z": 0.640917646713088}, "transcript": "ENST00000219368.3"}, "exons": [{"cdsend": 74774755, "cdsstart": 74714189, "chr": "16", "position": [[74712970, 74714269], [74716346, 74716599], [74718987, 74719160], [74726224, 74726331], [74727243, 74727386], [74740022, 74740115], [74774485, 74774820]], "strand": -1, "transcript": "NM_024306", "txend": 74774820, "txstart": 74712970}], "exons_hg19": [{"cdsend": 74808653, "cdsstart": 74748087, "chr": "16", "position": [[74746866, 74748167], [74750244, 74750497], [74752885, 74753058], [74760122, 74760229], [74761141, 74761284], [74773920, 74774013], [74808383, 74808718]], "strand": -1, "transcript": "NM_024306", "txend": 74808718, "txstart": 74746866}], "generif": [{"pubmed": 15337768, "text": "the human FA2H gene encodes a fatty acid 2-hydroxylase involved in the formation of myelin 2-hydroxy galactosylceramides and -sulfatides"}, {"pubmed": 17355976, "text": "late differentiation-linked increases in FA2H expression are essential for epidermal permeability barrier homeostasis."}, {"pubmed": 19068277, "text": "Mutations in FA2H are associated with leukodystrophy with spastic paraparesis and dystonia."}, {"pubmed": 19834535, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19844255, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20104589, "text": "Mutations in FA2H are associated with hereditary spastic paraplegia."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21592092, "text": "a novel homozygous c.270+3A>T mutation altered FA2H function led to a severe phenotype, with clinical features overlapping those in three FA2H-associated disorders"}, {"pubmed": 21599921, "text": "The 2-hydroxylated sphingomyelin (SM) profiles were characterized in blood and fibroblasts from patients harboring a deleterious FA2H mutation."}, {"pubmed": 22704260, "text": "This study did not find any mutations in the FA2H gene in patients with neurodegeneration with brain iron accumulation."}, {"pubmed": 22925154, "text": "we report a novel mutation in FA2H gene in two sibs presenting with adult onset complicated spastic paraparesis and thin corpus callosum"}, {"pubmed": 23535410, "text": "FA2H is a novel (9)-THC-regulated gene, and that (9)-THC induces differentiation signal(s) in poorly differentiated MDA-MB-231 cells."}, {"pubmed": 23566484, "text": "Identification of a novel triple heterozygous mutations in FA2H gene (c.968C>A; c.976G>A; c.688G>A) in a Chinese family with Hereditary Spastic Paraplegia Type 35."}, {"pubmed": 24299421, "text": "One heterozygous deletion within 16q22.3-q23.1 including FA2H was observed in two siblings who share symptoms of autism and severe cognitive impairment, axial T2-FLAIR weighted MRI posterior periventricular white matter lesions."}, {"pubmed": 24359114, "text": "Three novel mutations in Chinese patients significantly reduce FA2H enzyme activity leading to hereditary spastic paraplegia."}, {"pubmed": 25291031, "text": "Induced levels of PPARalpha may be involved in the Delta(9)-THC up-regulation of FA2H in MDA-MB-231 cells."}, {"pubmed": 25496456, "text": "Novel mutations in FA2H in Arab patients with a clinical spectrum of neurodegeneration and hereditary spastic paraparesis were identified."}, {"pubmed": 29423566, "text": "Study reports the clinical, neuroimaging, biochemical, and molecular findings in three novel unrelated patients with new mutations in FA2H, comparing their features with those previously reported in autosomal recessive spastic paraplegia 35 (SPG35)."}, {"pubmed": 29438993, "text": "PGRMC1 may regulate FA2H activity, possibly through its heme chaperone activity."}, {"pubmed": 30446360, "text": "Novel variant c.130C>T (p.Pro44Ser) in homozygous status in exon 1 of the FA2H gene is described in a Czech patient with SPG35."}, {"pubmed": 31087769, "text": "Hereditary spastic paraplegia type 35 caused by the FA2H mutation in a family from Mali has been described."}, {"pubmed": 31409741, "text": "High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma"}, {"pubmed": 32798015, "text": "Fatty acid 2-hydroxylase (FA2H) as a stimulatory molecule responsible for breast cancer cell migration."}, {"pubmed": 33064010, "text": "Overexpression of Fatty Acid 2-Hydroxylase is Associated with an Increased Sensitivity to Cisplatin by Ovarian Cancer and Better Prognoses."}, {"pubmed": 33203703, "text": "2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis."}, {"pubmed": 33246395, "text": "Exome sequencing of a Pakistani family with spastic paraplegia identified an 18 bp deletion in the cytochrome B5 domain of FA2H."}, {"pubmed": 36902339, "text": "Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases."}, {"pubmed": 37410270, "text": "The first reports of FA2H-associated neurodegeneration from two unrelated Iranian families."}, {"pubmed": 38306901, "text": "A Novel Homozygous Deletion Including Exon 1 of FA2H Gene Causes Spastic Paraplegia-35: Genetic and Lipidomics Analysis of the Patients."}], "genomic_pos": {"chr": "16", "end": 74774831, "ensemblgene": "ENSG00000103089", "start": 74712955, "strand": -1}, "genomic_pos_hg19": {"chr": "16", "end": 74808729, "start": 74746853, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001949", "qualifier": "involved_in", "term": "sebaceous gland cell differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006631", "qualifier": "involved_in", "term": "fatty acid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006633", "qualifier": "involved_in", "term": "fatty acid biosynthetic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006679", "qualifier": "involved_in", "term": "glucosylceramide biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006682", "qualifier": "involved_in", "term": "galactosylceramide biosynthetic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006682", "qualifier": "involved_in", "term": "galactosylceramide biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0030148", "qualifier": "involved_in", "term": "sphingolipid biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030258", "qualifier": "involved_in", "term": "lipid modification"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032286", "qualifier": "involved_in", "term": "central nervous system myelin maintenance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032287", "qualifier": "involved_in", "term": "peripheral nervous system myelin maintenance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042634", "qualifier": "involved_in", "term": "regulation of hair cycle"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0044857", "qualifier": "involved_in", "term": "plasma membrane raft organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046513", "pubmed": 15337768, "qualifier": "involved_in", "term": "ceramide biosynthetic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0061436", "pubmed": 17355976, "qualifier": "involved_in", "term": "establishment of skin barrier"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904002", "qualifier": "involved_in", "term": "regulation of sebum secreting cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904697", "qualifier": "involved_in", "term": "regulation of acinar cell proliferation"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "is_active_in", "term": "endoplasmic reticulum"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 15337768, "qualifier": "located_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0005506", "qualifier": "enables", "term": "iron ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0020037", "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0080132", "qualifier": "enables", "term": "fatty acid alpha-hydroxylase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0080132", "pubmed": [15337768, 15863841, 22517924], "qualifier": "enables", "term": "fatty acid alpha-hydroxylase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0080132", "pubmed": 17355976, "qualifier": "enables", "term": "fatty acid alpha-hydroxylase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0080132", "qualifier": "enables", "term": "fatty acid alpha-hydroxylase activity"}]}, "homologene": {"genes": [[3702, 818042], [4530, 4334311], [4530, 4352850], [4932, 855315], [5141, 3872026], [6239, 172882], [7227, 35670], [8364, 595069], [9031, 415687], [9544, 710403], [9598, 454243], [9606, 79152], [9615, 610417], [9913, 516891], [10090, 338521], [10116, 307855], [28985, 2893029], [33169, 4618594], [318829, 2677458]], "id": 56284}, "interpro": [{"desc": "Sterol desaturase Scs7", "id": "IPR014430", "short_desc": "Scs7"}, {"desc": "Cytochrome b5-like heme/steroid binding domain", "id": "IPR001199", "short_desc": "Cyt_B5-like_heme/steroid-bd"}, {"desc": "Fatty acid hydroxylase", "id": "IPR006694", "short_desc": "Fatty_acid_hydroxylase"}, {"desc": "Cytochrome b5, heme-binding site", "id": "IPR018506", "short_desc": "Cyt_B5_heme-BS"}, {"desc": "Cytochrome b5-like heme/steroid binding domain superfamily", "id": "IPR036400", "short_desc": "Cyt_B5-like_heme/steroid_sf"}], "ipi": ["IPI00304492", "IPI01009496"], "map_location": "16q23.1", "name": "fatty acid 2-hydroxylase", "other_names": ["fatty acid 2-hydroxylase", "fatty acid alpha-hydroxylase", "fatty acid hydroxylase domain containing 1", "fatty acid hydroxylase domain-containing protein 1", "spastic paraplegia 35 (autosomal recessive)"], "pantherdb": {"HGNC": "21197", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2443327", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 10090, "uniprot_kb": "Q5MPP0"}, {"RGD": "1310347", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 10116, "uniprot_kb": "Q2LAM0"}, {"Ensembl": "ENSGALG00000002775", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 9031, "uniprot_kb": "A0A3Q2UAW5"}, {"ZFIN": "ZDB-GENE-031219-4", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 7955, "uniprot_kb": "F1R936"}, {"WormBase": "WBGene00007707", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 6239, "uniprot_kb": "Q9XVS0"}, {"FlyBase": "FBgn0050502", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 7227, "uniprot_kb": "Q8SXY2"}, {"SGD": "S000004885", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 4932, "uniprot_kb": "Q03529"}, {"PomBase": "SPAC19G12.08", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 4896, "uniprot_kb": "O13846"}, {"dictyBase": "DDB_G0269908", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 352472, "uniprot_kb": "Q55CT7"}, {"TAIR": "2133054", "ortholog_type": "O", "panther_family": "PTHR12863", "taxid": 3702, "uniprot_kb": "Q9SUC5"}, {"TAIR": "2061564", "ortholog_type": "LDO", "panther_family": "PTHR12863", "taxid": 3702, "uniprot_kb": "O48916"}], "uniprot_kb": "Q7L5A8"}, "pathway": {"humancyc": {"id": "PWY66-388", "name": "fatty acid &alpha;-oxidation III"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1660661", "name": "Sphingolipid de novo biosynthesis"}, {"id": "R-HSA-428157", "name": "Sphingolipid metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}], "wikipathways": {"id": "WP4577", "name": "Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway"}}, "pfam": ["PF00173", "PF04116"], "pharmgkb": "PA145148065", "pharos": {"target_id": 20112, "tdl": "Tbio"}, "prosite": "PS50255", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF172413", "relationship": "is"}, {"id": "GNF183319", "relationship": "is"}, {"id": "GNF194225", "relationship": "is"}, {"id": "GNF205131", "relationship": "is"}, {"id": "GNF220434", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": [{"id": "GNF157234", "relationship": "is"}, {"id": "GNF161347", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": {"id": "GNF087987", "relationship": "is"}, "GNF_hs-druggable_plasmid-shRNA": {"id": "GNF059137", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF004327", "relationship": "is"}, {"id": "GNF004328", "relationship": "is"}, {"id": "GNF004329", "relationship": "is"}, {"id": "GNF004330", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": [{"id": "GNF239836", "relationship": "is"}, {"id": "GNF240127", "relationship": "is"}, {"id": "GNF285866", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF101956", "relationship": "is"}, {"id": "GNF141611", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1", "NG_017070.1"], "protein": ["NP_077282.3", "XP_011521619.1", "XP_011521621.1", "XP_054169881.1", "XP_054169882.1"], "rna": ["NM_024306.5", "XM_011523317.4", "XM_011523319.3", "XM_054313906.1", "XM_054313907.1"], "translation": [{"protein": "NP_077282.3", "rna": "NM_024306.5"}, {"protein": "XP_054169882.1", "rna": "XM_054313907.1"}, {"protein": "XP_054169881.1", "rna": "XM_054313906.1"}, {"protein": "XP_011521621.1", "rna": "XM_011523319.3"}, {"protein": "XP_011521619.1", "rna": "XM_011523317.4"}]}, "reporter": {"HG-U133_Plus_2": ["219429_at", "234963_s_at"], "HTA-2_0": "TC16001271.hg.1", "HuEx-1_0": "3699133", "HuGene-1_1": "8002792", "HuGene-2_1": "16828357"}, "retired": 724111, "summary": "This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010].", "symbol": "FA2H", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1427405"}, "unigene": "Hs.461329", "uniprot": {"Swiss-Prot": "Q7L5A8", "TrEMBL": ["A0A087WVM8", "J3QS89", "H3BP32"]}, "wikipedia": {"url_stub": "FA2H"}}